Managing Patients With Moderate Penetrance Genes

December 13, 2018
Susan M. Domchek, MD

Dr. Susan Domchek discusses the increased understanding of moderate penetrance genes and the importance of managing patients with these genes on a case-by-case basis.

Dr. Susan Domchek discusses the increased understanding of moderate penetrance genes and the importance of managing patients with these genes on a case-by-case basis.

Related Content:

SABCS Street TeamBreast Cancer
Real-World Evidence Supports Efficacy of Palbociclib Plus Letrozole in HR+/HER2– Breast Cancer
FDA Grants Full Approval to Sacituzumab Govitecan for Triple-Negative Breast Cancer
Cryoablation Technology for Early Breast Cancer Earns Breakthrough Therapy Designation